What specific patient populations benefit the most from ritlecitinib treatment?
Featuring Brittany Craiglow, MD |
Assistant Professor Adjunct Dermatology
Yale School of Medicine
New Haven, CT
Related Media
Powered by Polaris TMFeaturing Brittany Craiglow, MD |
Assistant Professor Adjunct Dermatology
Yale School of Medicine
New Haven, CT
Related Media
Powered by Polaris TM